厌氧活性指数的开发与应用
该研究基于21种抗生素对七类厌氧菌的体外药敏数据,构建了厌氧活性指数(AAI),并在烧伤患者队列中评估7天厌氧暴露与90天复合结局的关联。结果显示,最高AAI四分位组相比最低组复合结局风险增高(OR: 2.90; 95% CI: 1.65-5.08),提示AAI可作为评估抗厌氧菌抗生素影响的研究工具。
要点
- AAI量化21种抗生素的抗厌氧菌活性,评分范围4-59分。
- 美罗培南(59)、厄他培南(58)、替加环素(57)评分最高。
- 烧伤患者中高AAI暴露与90天复合结局风险增高相关。
核心结论
- 研究提出厌氧活性指数(AAI),为常用抗生素赋予抗厌氧菌活性的数值评分。
- 在烧伤患者队列中,最高AAI四分位组与最低组相比,90天复合结局的比值比为2.90(95% CI: 1.65-5.08)。
研究设计与样本
- 利用21种抗生素对七类厌氧菌的体外药敏数据生成AAI,并对药敏比例进行分箱以减少并列评分。
- 在烧伤患者队列中计算7天厌氧暴露(AAI乘以治疗天数后求和),采用多变量logistic回归分析AAI四分位与90天复合结局的关联。
主要发现
- 共纳入88篇报告厌氧活性的论文,AAI评分范围为4至59。
- 美罗培南(59)、厄他培南(58)和替加环素(57)评分最高,青霉素(20)、多西环素(13)和氨曲南(4)评分最低。
- 部分抗生素因数据缺乏未能纳入。
- 在烧伤患者队列中,调整Baux评分和Charlson合并症指数后,最高7天AAI四分位组相比最低组的90天复合结局比值比为2.90(95% CI: 1.65-5.08)。
临床怎么用
- AAI可作为研究工具,用于评估抗厌氧菌抗生素对患者结局的影响。
- 该评分需随新的药敏数据出现而更新。
局限性
- 部分抗生素因缺乏数据未能纳入AAI评分。
- AAI评分需随额外药敏数据的获得而更新。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Antibiotics with anaerobic activity may result in adverse patient outcomes. Here, we report the development and application of an Anaerobic Activity Index (AAI) to quantify anti-anaerobic antibiotic exposure. METHODS: The numeric AAI was generated for 21 antibiotics using in vitro susceptibility data for seven anaerobic bacterial groups. A binning strategy was applied to susceptibility proportions to result in the fewest antibiotic tied scores. In a cohort of patients with burns, 7-day anaerobic exposure was calculated, multiplied by days of therapy, and summed. Multivariable logistic regression models assessed the association between AAI quartiles and a 90-day composite outcome including culture positivity with bacteria of interest, healthcare-associated infection, and/or death. RESULTS: We included 88 papers reporting on anaerobic activity. The AAI ranged from 4 to 59. Meropenem (59), ertapenem (58), and tigecycline (57) were the highest ranked antibiotics, whereas penicillin (20), doxycycline (13), and aztreonam (4) had the lowest scores. Several antibiotics could not be included for lack of data. In a cohort of patients with burns, the highest seven-day AAI quartile was associated with increased odds of the 90-day composite outcome compared to the lowest quartile (OR: 2.90; 95% CI: 1.65-5.08), adjusting for Baux score and Charlson comorbidity index. CONCLUSIONS: We propose an anaerobic activity index (AAI) assigning numeric scores to commonly used antibiotics. We anticipate that this score will require updating as additional susceptibility data become available. The AAI may be used as a research tool evaluating the impact of anti-anaerobic antibiotics on patient outcomes.
引用
- Mackow NA, Komarow L, Napravnik S, et al. Development and Application of an Anaerobic Activity Index. Clin Infect Dis. 2026. PMID: 42548283. doi:10.1093/cid/ciag470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。